Stocktoria

Cingulate Inc. CING

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-10-07

Cingulate Inc. statistics & valuation

Market cap$66.8M
P / B26.6×
Return on capital-418.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-555.80% -99.40% -455.30% -222.10% -894.80% 202020212022202320242025
Shares outstanding
11.3M 602640 97293 3.4M 7.3M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-124.10% -90.50% -155.00% -674.10% -111.40% -148.90% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$29.35 -$311.99 -$10.86 -$4.44 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-148.9%-111.4%-674.1%-155.0%-90.5%-124.1%
Return on equity-894.8%-222.1%342.6%-455.3%-99.4%-555.8%
Current ratio1.162.550.061.1216.050.53

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.